FDA 483 - Federal Package Network, Inc - December 13, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Federal Package Network, Inc. in Chanhassen, MN, a drug manufacturer, revealed significant deficiencies in their quality system. The firm was cited for inadequate laboratory controls, including unvalidated HPLC methods and poor data integrity practices, as well as failures in thoroughly investigating discrepancies and out-of-specification results. Additionally, the inspection found issues with process validation for OTC drug products and a lack of adherence to quality unit responsibilities.
ID · 33d9da0a-dd58-4ab8-95b9-aa844eb288ed